TCTMD
Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
MedPage Today on MSN
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
Nasal spray OK'd for unsupervised treatment of paroxysmal supraventricular tachycardia ...
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...
Milestone Wins FDA Approval For First Self-Use Nasal Spray For Sudden Fast Heartbeats
The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...